top of page
ATXA Therapeutics Limited is a private company limited by shares.
Registered in Ireland No. 561857
Our pipeline is protected by a growing worldwide patent estate and we have secured Orphan Designation from the EMA (Europe) and the FDA (USA) for our lead drug NTP42 for its primary target indication PAH.
bottom of page